贝瑞基因(000710.SZ)发布前三季度业绩，归母净亏损5256.37万元

Group 1 - The core viewpoint of the article is that Berry Genomics (000710.SZ) reported a decline in revenue and incurred a net loss for the first three quarters of 2025 [1] Group 2 - For the first three quarters, the company achieved an operating income of 686 million yuan, representing a year-on-year decrease of 16.65% [1] - The net loss attributable to shareholders of the listed company was 52.5637 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 53.7914 million yuan [1]